Ekaterina (Katya) Nevedomskaya, PhD

Critic
DISC Type : C

Director, Computational Biology Lead at Bayer

Berlin, Berlin, Germany

Overview

Ekaterina is a results-driven computational biologist and the Director, Computational Biology Lead at Bayer, specializing in oncology drug discovery. With a PhD from Leiden University Medical Center, she leverages her expertise in genomics to lead strategic initiatives and is recognized as a Bayer Science Fellow. Colleagues describe her as dedicated, with an enormous grasp of biology and expertise in data analysis.

Outside of her work in oncology, Ekaterina shows a keen interest in the broader technology and startup ecosystem. She is a vocal supporter of her husbands entrepreneurial journey with his hydromet startup, Orbisens®, celebrating their vision and teamwork. This reflects her passion for innovation that extends beyond her professional domain.

Unique fact: Ekaterina holds a certification in the "Ethical and Social Challenges of Genomic and Precision Medicine, " underscoring her commitment to the responsible application of science.

Personality Overview

Objective Thinker

Negotiator

ROI Driven

They choose to analyze logically and value facts to emotions.  It is very likely that they will negotiate pricing or other important terms. They like to do things independently and don’t look for support from others.

Topics They Care About

Oncology Drug Discovery
Leads strategy for oncology pipeline replenishment at Bayer, using omics analytics and genomic insights for novel target identification.
Computational Biology
Her core expertise, involving the analysis of large volumes of Next Generation Sequencing data to drive biological and clinical interpretation in cancer research.
Innovative Team Building
Committed to creating a safe and collaborative environment that empowers her global computational biology teams to thrive and innovate.

Media Appearances

Ekaterina has no verified media appearances

Work History

6-2024
Director, Computational Biology Lead at Bayer
1-2021
Bayer Science Fellow at Bayer
5-2023 - 5-2024
Director, Head of Preclinical Analytics at Bayer
6-2013 - 5-2017
Postdoctoral Fellow at Netherlands Cancer Institute/Antoni van Leeuwenhoek hospital
9-2011 - 6-2013
Postdoctoral Researcher at Leiden University Medical Center

Education

2007 - 2011
PhD from Leiden University Medical Center
2002 - 2007
MSc from Lomonosov Moscow State University (MSU)

More Information

Social Presence :

Prographics :

Exp : 10 Location : Berlin, Berlin, Germany Job Level : Mid-senior Designation : Director, Computational Biology Lead at Bayer
URL has been copied!

Insights For Selling To Ekaterina (Katya)

During A Call Or A Meeting

DO's

  • Use phrases like ‘expect X% improvement’, ‘data clearly shows’ etc.
  • Be ready for penetrating questions and critical examination of your pitch
  • Tell them what ROI they can expect

DONT's

  • Avoid phrases like ‘trust me’, ‘others just love’ etc.
  • Don't give superficial answers, they are easily rattled by them
  • Make extra effort to not seem pushy or confrontational

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Ekaterina (Katya) is

  • Proven ROI, pricing and objective proof points are the factors that sway their decision.
  • Will you ever get a clear answer from Ekaterina (Katya)

  • They are comfortable saying no if they are convinced that it is the correct decision.

Insights For Deal Planning

    How fast (or slow) will Ekaterina (Katya) move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Ekaterina (Katya) take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Ekaterina (Katya)

Personality Compatibility


Other Bayer Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.